Mbiomics raises €5.0M Series A round
4 August 2025· Munich, Germany· health, biotech, ai, b2b, software_hardware
This represents the extension or final closing of the Series A round, bringing the total raised for the stage to €18 million. The capital supports further platform development, data analytics, GMP production, and clinical trial execution.
Investors
LeadMIG Capital
Also participating
High-Tech GründerfondsBayern Kapital
About Mbiomics
Stage
Series A
Headquarters
Munich, Germany
Founded
2020
Team Size
21–50
Sectors
healthbiotechaib2bsoftware_hardware